Biogen Pharmachem Industries Limited (BOM:531752)

BOM:531752 Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May 19, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	282	333	627	692	385	914
Market Cap Growth	-51.50%	-46.88%	-9.43%	79.66%	-57.86%	566.67%
Enterprise Value	278	329	623	747	385	913
Last Close Price	0.37	0.44	0.82	0.91	0.51	1.20
PE Ratio	43.02	38.72	-	35.83	84.53	-
PS Ratio	11.01	13.01	52.31	87.67	153.83	36.83
PB Ratio	0.28	0.34	0.68	1.22	0.71	1.69
P/TBV Ratio	0.28	0.34	0.68	1.22	0.71	1.69
P/OCF Ratio	17.96	21.22	-	35.57	22.59	65.34
EV/Sales Ratio	10.89	12.87	52.04	94.61	153.76	36.82
EV/EBIT Ratio	29.11	34.41	-	220.68	-	300.77
Net Debt / Equity Ratio	0.00	0.00	-0.02	0	0.00	0.00
Asset Turnover	0.03	0.03	0.02	0.01	0.01	0.05
Quick Ratio	1.50	1.50	28.71	0.06	0.54	2.36
Current Ratio	2.27	2.27	29.65	0.30	0.65	2.37
Return on Equity (ROE)	0.90%	0.90%	-0.39%	3.48%	0.84%	-0.02%
Return on Assets (ROA)	0.63%	0.63%	-0.23%	0.38%	-0.22%	0.35%
Return on Invested Capital (ROIC)	0.87%	0.91%	-0.37%	0.61%	-0.35%	0.56%
Return on Capital Employed (ROCE)	1.00%	1.00%	-0.30%	0.60%	-0.40%	0.60%
Earnings Yield	3.05%	2.58%	-0.47%	2.79%	1.18%	-0.01%
Buyback Yield / Dilution	-31.27%	-31.27%	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.